Skip to main content
Log in

Novel method for deriving AE prevalence in RCTs

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Piacentino D, et al. A Novel Method for Deriving Adverse Event Prevalence in Randomized Controlled Trials: Potential for Improved Understanding of Benefit-Risk Ratio and Application to Drug Labels. Advances in Therapy : 19 Oct 2023. Available from: URL: http://doi.org/10.1007/s12325-023-02695-8

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Novel method for deriving AE prevalence in RCTs. Reactions Weekly 1980, 8 (2023). https://doi.org/10.1007/s40278-023-48200-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-48200-7

Navigation